We are live on ! Find out more
PTC

Philadelphia Trust Company Portfolio holdings

AUM $1.42B
1-Year Est. Return 43.77%
This Fund
S&P 500
This Quarter Est. Return
+10.08%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.45B
AUM Growth
+$150M
Cap. Flow
+$33.3M
Cap. Flow %
2.3%
Top 10 Hldgs %
31.97%
Holding
239
New
25
Increased
56
Reduced
99
Closed
14

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$12.7M
2
KYNB
Kyntra Bio
KYNB
+$7.58M
3
AYX
Alteryx Inc
AYX
+$6.92M
4
ASO icon
Academy Sports + Outdoors
ASO
+$4.44M
5
NWL icon
Newell Brands
NWL
+$3.65M

Sector Composition

Rank Sector Weight
1 Technology 26.92%
2 Healthcare 18.54%
3 Communication Services 13.54%
4 Financials 12.39%
5 Industrials 10.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
151
Chevron
CVX
$366B
$798K 0.06%
7,620
+510
+7% +$53.8K
REGN icon
152
Regeneron Pharmaceuticals
REGN
$80.8B
$782K 0.05%
1,400
IWM icon
153
iShares Russell 2000 ETF
IWM
$81.9B
$780K 0.05%
3,399
+1,205
+55% +$271K
ITW icon
154
Illinois Tool Works
ITW
$84.5B
$765K 0.05%
3,420
TFC icon
155
Truist Financial
TFC
$64B
$748K 0.05%
13,477
-3,075
-19% -$181K
WTRG icon
156
Essential Utilities
WTRG
$11.4B
$738K 0.05%
16,145
DKNG icon
157
DraftKings
DKNG
$11.9B
$699K 0.05%
13,401
+300
+2% +$15.8K
PPL
158
PPL Corp
PPL
$26.7B
$694K 0.05%
24,808
-2,376
-9% -$68.7K
SPGI icon
159
S&P Global
SPGI
$120B
$667K 0.05%
1,626
+1
+0.1% +$384
ALXN
160
DELISTED
Alexion Pharmaceuticals
ALXN
$661K 0.05%
3,600
-50
-1% -$8.58K
CSCO icon
161
Cisco
CSCO
$479B
$645K 0.04%
12,170
+1,195
+11% +$62.9K
JHI
162
John Hancock Investors Trust
JHI
$117M
$642K 0.04%
34,063
-250
-0.7% -$4.62K
DUK icon
163
Duke Energy
DUK
$97.3B
$633K 0.04%
6,413
-519
-7% -$52.1K
PM icon
164
Philip Morris
PM
$295B
$632K 0.04%
6,375
+250
+4% +$24K
HPS
165
John Hancock Preferred Income Fund III
HPS
$458M
$620K 0.04%
32,300
HDV
166
iShares Core High Dividend ETF
HDV
$14.8B
$619K 0.04%
32,085
AXP icon
167
American Express
AXP
$230B
$602K 0.04%
3,645
+10
+0.3% +$1.57K
EQIX icon
168
Equinix
EQIX
$103B
$601K 0.04%
749
-5
-0.7% -$3.71K
XYL icon
169
Xylem
XYL
$28.1B
$569K 0.04%
4,747
CL icon
170
Colgate-Palmolive
CL
$74.4B
$565K 0.04%
6,942
-992
-13% -$81.1K
STBA icon
171
S&T Bancorp
STBA
$1.79B
$542K 0.04%
17,325
ACWX icon
172
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
$524K 0.04%
+9,115
New +$523K
WPC icon
173
W.P. Carey
WPC
$16.4B
$522K 0.04%
7,147
CMI icon
174
Cummins
CMI
$88.7B
$517K 0.04%
2,120
-75
-3% -$19.2K
LOW icon
175
Lowe's Companies
LOW
$125B
$509K 0.04%
2,624
+438
+20% +$85.7K

Similar funds

Philadelphia Trust Company's Q2 2021 Portfolio in Review

As of Q2 2021, Philadelphia Trust Company held 239 positions worth $1.45B, up 12% from $1.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Philadelphia Trust Company's Q2 2021 filing shows 25 new, 56 increased, 99 reduced and 14 closed positions. Its largest new stake was Citizens Financial Group: 363,420 shares worth $16.7M. The largest sale was Biogen, an estimated $12.7M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Communication Services.

  • Philadelphia Trust Company's largest Q2 2021 buy was Citizens Financial Group: 363,420 shares worth $16.7M.
  • Philadelphia Trust Company added most to Carrier Global in Q2 2021, an estimated $13.9M increase.
  • Philadelphia Trust Company's biggest Q2 2021 reduction was Biogen, cutting an estimated $12.7M.
  • Philadelphia Trust Company fully exited Kyntra Bio in Q2 2021, selling an estimated $7.58M.
  • Philadelphia Trust Company's ten largest holdings make up 32% of its $1.45B portfolio in Q2 2021.
  • Philadelphia Trust Company opened 25 new positions and closed 14 in Q2 2021.
  • Philadelphia Trust Company's portfolio value rose 12% quarter-over-quarter to $1.45B.

Based on Philadelphia Trust Company's 13F filing for Q2 2021, filed 13 Aug 2021.